Valuation Astellas Pharma Inc. OTC Markets

Stocks

ALPMY

US04623U1025

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 15:59:52 2026-07-31 EDT			5-day change	1st Jan Change
13.73 ^USD	-4.79%		+4.89%	+3.31%

07-12	Pfizer, Astellas Secure FDA Nod For Bladder Cancer Drug	MT
07-10	Health Care Down on Rotation Back to Tech - Health Care Roundup	DJ

Company Valuation: Astellas Pharma Inc.

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	3,519,738	3,381,409	2,946,773	2,589,390	4,512,563	3,944,866	-	-
Change	-	-3.93%	-12.85%	-12.13%	74.27%	-12.58%	-	-
Enterprise Value (EV) ¹	3,203,752	3,004,569	2,611,086	3,232,444	4,796,910	3,814,792	3,472,562	3,150,933
Change	-	-6.22%	-13.1%	23.8%	48.4%	-20.47%	-8.97%	-9.26%
P/E	28.5x	34.7x	173x	51x	15.5x	11.5x	11.9x	15.8x
PBR	2.39x	2.24x	1.85x	1.71x	2.47x	1.98x	1.83x	1.76x
PEG	-	-1.8x	-2.1x	0x	0x	0.7x	-3.6x	-0.6x
Capitalization / Revenue	2.72x	2.23x	1.84x	1.35x	2.11x	1.75x	1.9x	2.14x
EV / Revenue	2.47x	1.98x	1.63x	1.69x	2.24x	1.69x	1.67x	1.71x
EV / EBITDA	13.6x	12.6x	14.2x	13.5x	8.31x	5.86x	5.55x	6.18x
EV / EBIT	20.6x	22.6x	102x	78.8x	12.5x	8.38x	7.96x	9.12x
EV / FCF	14.1x	10.3x	-3.88x	20.5x	9.72x	9.05x	6.74x	6.93x
FCF Yield	7.08%	9.7%	-25.8%	4.87%	10.3%	11%	14.8%	14.4%
Dividend per Share ²	50	60	70	74	78	80.31	82.92	85.25
Rate of return	2.62%	3.19%	4.26%	5.12%	3.1%	3.65%	3.77%	3.87%
EPS ²	67.08	54.24	9.51	28.35	162.8	191.4	185.1	139.2
Distribution rate	74.5%	111%	736%	261%	47.9%	42%	44.8%	61.2%
Net sales ¹	1,296,163	1,518,619	1,603,672	1,912,323	2,139,245	2,259,518	2,079,011	1,843,965
EBITDA ¹	235,370	238,767	183,358	240,171	577,227	651,031	625,569	510,234
EBIT ¹	155,686	133,029	25,518	41,039	382,633	455,432	436,500	345,577
Net income ¹	124,086	98,714	17,045	50,747	291,535	342,532	330,764	248,432
Net Debt ¹	-315,986	-376,840	-335,687	643,054	284,347	-130,074	-472,304	-793,933
Reference price ²	1,911.00	1,883.00	1,643.50	1,446.50	2,519.00	2,202.00	2,202.00	2,202.00
Nbr of stocks (in thousands)	1,841,831	1,795,756	1,792,986	1,790,107	1,791,411	1,791,492	-	-
Announcement Date	4/27/22	4/27/23	4/25/24	4/25/25	4/27/26	-	-	-

¹JPY in Million²JPY

Estimates

P/E, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	34.3x	12.25x	25.74x	0.59%	1,030B
JOHNSON & JOHNSON	27.42x	6.27x	17.37x	2.1%	617B
ABBVIE INC.	32.4x	7.6x	15.6x	2.67%	455B
ROCHE HOLDING AG	19.58x	4.68x	11.59x	2.83%	350B
NOVARTIS AG	22.31x	5.76x	14.38x	2.78%	299B
ASTRAZENECA PLC	21.88x	4.51x	12.77x	1.94%	265B
NOVO NORDISK A/S	14.62x	5.41x	11.16x	3.43%	225B
AMGEN INC.	25.46x	6.65x	11.72x	2.6%	209B
GILEAD SCIENCES, INC.	-47.31x	5.67x	31.32x	2.51%	163B
Average	16.74x	6.53x	16.85x	2.38%	401.41B
Weighted average by Cap.	24.14x	7.76x	18.30x	1.99%